Does this PSA testing study affect how RCOG thinks doctors should approach prostate cancer screenings?
No. Although it is important to evaluate the results of new research studies, annual PSA testing is still the standard of care in the detection and diagnosis of prostate cancer. PSA testing has been in widespread use for more than 20 years and has proven both instrumental and effective. The use of PSA testing has allowed early diagnosis so that a treatment like ProstRcision can be applied promptly. This has contributed partially to the achievement of an 83 percent cure.
